Skip to content

To compare efficacy of kokilakshadi kashayam & kaishore gugguluin management of vatarakra wsr to gout

A comparative study to evaluate the efficacy of kokilakshadi kashayam & kaishore guggulu in management of vatarakta wsr to gout - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055000
Enrollment
60
Registered
2023-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

None listed

Sponsors

Shri krishna government ayurvedic college and hospital sec 8 umri road kurukshetra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between the age group of 19-60 years of either sex presented with clinical features of VataRakta/ Gout. 2.Diagnosed and confirmed the case of VataRakta (Gout). 3.Patients have serum uric acid levels of more than 6mg/dl in females & more than 7mg/dl in males with or without any associated features like joint pain and inflammation.

Exclusion criteria

Exclusion criteria: 1.Patients below 19 years and above 60 years will be excluded 2.Patients suffering from other forms of Arthritis like Rheumatoid arthritis, Osteoarthritis, Ankylosing spondylitis, Infective arthritis, etc. 3.Pregnant and lactating mother. 4.Subject showing the uric acid level above 9mg/dl. 5.Patients with evidence of malignancy & on chemotherapy drugs. 6.Patients having any disorders like Diabetes mellitus, Cardiac disease, CRF, ARF, etc.

Design outcomes

Primary

MeasureTime frame
The efficacy of Kokilakshadi Kashayam and Kaishore Guggulu will be noted in respective groups as per changes in subjective criteria on the 15th 30th day and 60th-day post-treatment and repeat lab investigation (CBC, ESR, CRP (Quantitative), Serum UA, Blood Urea, Serum Creatinine, RA Factor) will be done post-treatment.Timepoint: 30 days of treatment with follow up on 15th, 30th and 60th day

Secondary

MeasureTime frame
1) To Compare efficacy of Kokilakshadi Kashaya & Kaishore Guggulu after complete treatment & follow up of both groups. 2.Evalution of adverse effect of both drug will be done on each patient during & post treatment.Timepoint: Final result will be checked post treatment of all patients from both groups & will take approx 1 year 2) Adverse effects will be noted on each patient & each follow up till 60th day

Countries

India

Contacts

Public ContactAnjali Jamra

Shri Krishna government ayurvedic college and hospital

drlamba.neha@gmail.com9736333868

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026